| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/13/2006 | EP1700866A2 Cerebral organic anion transporter and its gene |
| 09/13/2006 | EP1699920A2 Novel recombinant proteins with n-terminal free thiol |
| 09/13/2006 | EP1699914A2 Novel sodium channel |
| 09/13/2006 | EP1699824A2 Ztnf 12, a tumor necrosis factor |
| 09/13/2006 | EP1699822A2 Il-7 fusion proteins with antibody portions, their preparation and their use |
| 09/13/2006 | EP1699487A2 Novel anti-dc-sign antibodies |
| 09/13/2006 | EP1699469A2 Recombinant factor viii having increased specific activity |
| 09/13/2006 | EP1699420A1 Membranes incorporating recognition moieties |
| 09/13/2006 | EP1539989A4 Synthesis of oligosaccharides, glycolipids and glycoproteins using bacterial glycosyltransferases |
| 09/13/2006 | EP1535046A4 Screening antibodies using an optical fiber array device capable of simultaneously performing multiple functional assays |
| 09/13/2006 | EP1535045A4 Screening compound libraries using an optical fiber array device capable of simultaneously performing multiple functional assays |
| 09/13/2006 | EP1363944B1 High-affinity antagonists of elr-cxc chemokines |
| 09/13/2006 | EP1339840B1 Schizophrenia-related voltage-gated ion channel gene and protein |
| 09/13/2006 | EP1312677B1 Nucleic acids encoding lettuce big-vein virus proteins and utilization thereof |
| 09/13/2006 | EP1302477B1 Peptide fructose and complex thereof with binding protein |
| 09/13/2006 | EP1196579B1 Tryptase inhibitor |
| 09/13/2006 | EP1163272B1 Antibodies specific for cyp1b1 |
| 09/13/2006 | EP1088084B1 Erythropoietin analog-human serum albumin fusion protein |
| 09/13/2006 | EP0832093B1 Expression of lipoproteins |
| 09/13/2006 | EP0811065B1 Antagonists of interleukin-15 |
| 09/13/2006 | EP0773296B1 Secretory signal gene and expression vector having the same |
| 09/13/2006 | EP0755446B1 Cardiotrophin and uses therefor |
| 09/13/2006 | CN1833031A Casein hydrolyzate, process for producing the same and use thereof |
| 09/13/2006 | CN1833030A Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
| 09/13/2006 | CN1832958A Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 09/13/2006 | CN1831126A High secretion expression of recombination thymosin-alpha 1 in Escherichia coli and separation and purification therefor |
| 09/13/2006 | CN1831012A Immunological adjuvant with immunity vegulating agent for treating and preventing diabetic from insulin-dependent |
| 09/13/2006 | CN1274838C Method for preparing protein polypeptide through enzymolysis of cow milk |
| 09/13/2006 | CN1274835C Fusion expression method of mycobacterium tuberculosis ESAT-6 protein in pichia |
| 09/13/2006 | CN1274829C Anti EB virus resulted tumour polypeptide, and its use and preparing method |
| 09/13/2006 | CN1274823C Production of human interleukin 288 and recombined IL-288 engineering bacteria |
| 09/13/2006 | CN1274717C Immune suppression fusion protein, its coded nucleic acid and application |
| 09/13/2006 | CN1274715C Memno peptides, a process for their preparation and their use |
| 09/13/2006 | CN1274361C Soybean peptide, its preparation and application |
| 09/12/2006 | US7105725 Pathogen resistant transgenic plants expressing CEMA or CEMA-related peptides |
| 09/12/2006 | US7105722 For altering the phenotype of a plant; increased fatty acid content in oilseeds |
| 09/12/2006 | US7105652 Human tumor suppressor gene |
| 09/12/2006 | US7105651 Nucleotide sequences coding polypeptide for use in the treatment of cancer, inflammation and infection; for use as pesticide and antibiotic |
| 09/12/2006 | US7105649 Gene and amplification with polynucleotides having amino acid sequence |
| 09/12/2006 | US7105641 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents |
| 09/12/2006 | US7105485 HO-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 09/12/2006 | US7105484 GDNF receptorα |
| 09/12/2006 | US7105347 Using surface-mediated protein transfected cell microarrays to screen polypeptide and enzyme activities; high throughput assay; drug screening |
| 09/12/2006 | US7105336 Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter |
| 09/12/2006 | US7105333 Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon |
| 09/12/2006 | US7105330 Immunoglobulin for detection and isolation of preferential glycosidase; tumor diagnosis and antitumor agents |
| 09/12/2006 | US7105324 Nucleic acid isolated from Tetrahymena which codes for a triterpenoid cyclase, its production, and use |
| 09/12/2006 | US7105321 Nucleotide sequences which code for the ccpA2 gene |
| 09/12/2006 | US7105317 Immunogenic compositions comprising vrg-gene products from Bordetella extracts |
| 09/12/2006 | US7105316 Neisseria lactoferrin binding protein |
| 09/12/2006 | US7105315 A cDNA encoding the protein, and an antibody that specifically binds the protein and their use to diagnose, to stage, to treat, or to monitor the progression or treatment of neoplastic disorders |
| 09/12/2006 | US7105313 Contacting mammal cell with mutant coding reporter molecule; calibration gene expression |
| 09/12/2006 | US7105305 Human platelet-derived growth factor receptors |
| 09/12/2006 | US7105303 Antibodies to hepatitis C virus asialoglycoproteins |
| 09/12/2006 | US7105296 Flavoproteins for esterification of ketones and ketoterpenes |
| 09/12/2006 | US7105291 Detecting sensitivity to kidney disease |
| 09/12/2006 | US7105290 Detect compound which binds to bone morphogenic protein receptors; obtain sample, incubate with binding agent, allow binding, detect complex formation between binding agent and receptors |
| 09/12/2006 | US7105159 Purified monoclonal antibody which binds to a fragment of an outer membrane domain of prostate specific membrane antigen, PSM antigen antibodies conjugated to a radioisotope or a toxin;measuring the amount of PSM antigen in a biological sample |
| 09/12/2006 | CA2241174C Expression augmenting sequence elements (ease) for eukaryotic expression systems |
| 09/12/2006 | CA2039021C Dna sequence comprising a structural gene coding for xylose reductase and/or xylitol dehydrogenase |
| 09/08/2006 | WO2006093794A1 Heterodimeric protein binding compositions |
| 09/08/2006 | WO2006093411A1 Cyanophycin production from nitrogen-containing chemicals obtained from biomass |
| 09/08/2006 | WO2006093128A1 Anti-megsin monoclonal antibody |
| 09/08/2006 | WO2006093088A1 Novel polypeptide, polynucleotide encoding the polypeptide and use the polypeptide and polynucleotide |
| 09/08/2006 | WO2006093080A1 PROCESS FOR PRODUCTION OF CHICKEN RECOMBINANT DIVALENT ANTIBODY FROM CHICKEN SINGLE-CHAIN VARIABLE FRAGMENT (scFv) AND ANTIBODY PRODUCED BY THE PROCESS |
| 09/08/2006 | WO2006093071A1 ANTI-IDIOTYPE ANTIBODY HAVING ANTIFUNGAL ACTIVITY ON FUNGUS CARRYING β-GLUCAN SYNTHASE AND UTILIZATION OF THE SAME |
| 09/08/2006 | WO2006092313A1 Lipopeptides having pharmaceutical activity |
| 09/08/2006 | WO2006041488A8 Immortalized hepatocytes |
| 09/08/2006 | WO2005089372A3 Therapeutic synergy of anti-cancer compounds |
| 09/08/2006 | WO2005051307A3 Epha2 agonistic monoclonal antibodies and methods of use thereof |
| 09/08/2006 | WO2005033290A3 Methods for altering mrna splicing and treating familial dysautonomia and other mechanistically related disorders |
| 09/08/2006 | CA2599265A1 Heterodimeric protein binding compositions |
| 09/07/2006 | US20060199947 Naturally-occurring variants of B7 proteins produced by alternative RNA splicing or alternative termination of full-length amino acid sequence; regulation of immune response in an animal; immunostimulants; anticarcinogenic agents, infections; antiallergens; antiinflammatory agents; veterinary medicine |
| 09/07/2006 | US20060199766 Pharmaceutical composition comprising a factor VIIa and a factor XIII |
| 09/07/2006 | US20060199251 Cleavage of fusion proteins using granzyme b protease |
| 09/07/2006 | US20060199250 Method for generating a mutant protein which efficiently binds a target molecule |
| 09/07/2006 | US20060199249 Method for protein production |
| 09/07/2006 | US20060199248 Q3 SPARC deletion mutant and uses thereof |
| 09/07/2006 | US20060199247 Method for identifying modulators gene expression |
| 09/07/2006 | US20060199246 Zinc-regulated prokaryotic expression cassettes |
| 09/07/2006 | US20060199245 vector and host cell comprising sequence for creating protein; producing a correctly-folded disulfide-rich peptide |
| 09/07/2006 | US20060199226 Functional bioluminescence energy resonance transfer (BRET) assay to screen, identify and characterize receptor tyrosine kinase ligands |
| 09/07/2006 | US20060199225 Modified chitin binding domain and uses thereof |
| 09/07/2006 | US20060199195 Nucleic acid encoding Schwannomin-Binding-Proteins and products related thereto |
| 09/07/2006 | US20060199190 Detection and typing of bacterial strains |
| 09/07/2006 | US20060199184 Fusion protein is a partial fragment of developmentally regulated endothelial cell locus-1 (Del-1) protein; gene expression; drug delivery; side effect reduction |
| 09/07/2006 | US20060199177 T helper cell epitopes |
| 09/07/2006 | US20060198849 Preparation method of igy for preventing and cure mouth disease and the toothpaste base on the igy |
| 09/07/2006 | US20060198845 Monoclonal antibody against human hepatoma and use thereof |
| 09/07/2006 | US20060198792 SBD from glucoamylase of fungi genus Rhizopus for use as a tag; a recombinant protein containing this sequence can be more easily purified and separated by contacting with an affinity matrix such as starch, to which it will bind |
| 09/07/2006 | US20060198784 Methods of treatment using antibodies to Neutrokine-alpha |
| 09/06/2006 | EP1698901A1 Method for detecting N-terminal proBNP |
| 09/06/2006 | EP1698703A1 Process for producing dipeptide |
| 09/06/2006 | EP1698698A1 Cell expansion lethal toxin and detection of bacterium belonging to campylobacter genus that targets the same |
| 09/06/2006 | EP1698694A1 Method of obtaining gene tag |
| 09/06/2006 | EP1698638A1 Lipopeptides having pharmaceutical activity |
| 09/06/2006 | EP1698347A2 hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/06/2006 | EP1697748A2 Methods for generating multimeric molecules |
| 09/06/2006 | EP1697542A2 Compositions and methods of using apoptosis signaling kinase related kinase (askrk) |
| 09/06/2006 | EP1697534A2 Nucleic acid molecules containing recombination sites and methods of using the same |